These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 5022455

  • 1. Comparative trial of low dose haloperidol and fluphenazine in office patients.
    Ayd FJ.
    Dis Nerv Syst; 1972 Mar; 33(3):192-5. PubMed ID: 5022455
    [No Abstract] [Full Text] [Related]

  • 2. Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
    McLaren S, Cookson JC, Silverstone T.
    Int Clin Psychopharmacol; 1992 Nov; 7(2):67-72. PubMed ID: 1487623
    [Abstract] [Full Text] [Related]

  • 3. Haloperidol for psychiatric disorders in children.
    Serrano AC, Forbis OL.
    Dis Nerv Syst; 1973 Nov; 34(5):226-31. PubMed ID: 4273764
    [No Abstract] [Full Text] [Related]

  • 4. Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.
    Levenson AJ, Burnett GB, Nottingham JD, Sermas CE, Thornby JI.
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):695-700. PubMed ID: 825356
    [No Abstract] [Full Text] [Related]

  • 5. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics.
    Hall WB, Vestre ND, Schiele BC, Zimmermann R.
    Dis Nerv Syst; 1968 Jun; 29(6):405-8. PubMed ID: 4877748
    [No Abstract] [Full Text] [Related]

  • 6. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
    Greger J, Glitschka A, Müller K.
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
    [No Abstract] [Full Text] [Related]

  • 7. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K.
    Acta Psychiatr Belg; 1982 Jun; 82(2):216-23. PubMed ID: 7180558
    [Abstract] [Full Text] [Related]

  • 8. Maintenance treatment of schizophrenia with long-acting fluphenazine.
    Niturad A, Ciurezu T, Cucu I.
    Act Nerv Super (Praha); 1974 Aug; 16(3):167. PubMed ID: 4154028
    [No Abstract] [Full Text] [Related]

  • 9. Assessment and significance of changes in laboratory values with haloperidol and fluphenazine hydrochloride therapy.
    Holden JM, Itil TM, Keskiner A.
    Biol Psychiatry; 1970 Apr; 2(2):173-82. PubMed ID: 4918019
    [No Abstract] [Full Text] [Related]

  • 10. Depression in schizophrenia: clinical and pharmacological variables.
    Mauri MC, Bravin S, Mantero M, Invernizzi G.
    Schizophr Res; 1995 Feb; 14(3):261-2. PubMed ID: 7766539
    [No Abstract] [Full Text] [Related]

  • 11. A double-blind comparison of fluphenazine and haloperidol in outpatient schizophrenic children.
    Engelhardt DM, Polizos P, Waizer J, Hoffman SP.
    J Autism Child Schizophr; 1973 Feb; 3(2):128-37. PubMed ID: 4583792
    [No Abstract] [Full Text] [Related]

  • 12. A butyrophenone (haloperidol) for the treatment of institutionalized patients.
    Lapolla A, Nash LR.
    Int J Neuropsychiatry; 1966 Apr; 2(2):129-34. PubMed ID: 5335397
    [No Abstract] [Full Text] [Related]

  • 13. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 14. The depot fluphenazines: a reappraisal after 10 years' clinical experience.
    Ayd FJ.
    Am J Psychiatry; 1975 May; 132(5):491-500. PubMed ID: 1091162
    [No Abstract] [Full Text] [Related]

  • 15. A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W, Boisvert D, Bradwejn J.
    Psychopharmacol Bull; 1984 May; 20(1):108-9. PubMed ID: 6371871
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of phenothiazine and nonphenothiazine neuroleptics according to psychopathology, side effects and computerized EEG.
    Itil TM, Patterson CD, Keskiner A, Holden JM.
    Adv Biochem Psychopharmacol; 1974 May; 9(0):499-509. PubMed ID: 4599437
    [No Abstract] [Full Text] [Related]

  • 17. Long-acting therapy of schizophrenia.
    Rapisarda V, Bonomo V, Parisi R.
    Adv Biochem Psychopharmacol; 1985 May; 40():25-8. PubMed ID: 4025038
    [No Abstract] [Full Text] [Related]

  • 18. [Policlinical schizophrenia therapy with longtime neuroleptic agent fluphenazine decanoate].
    Haase HJ, Steuer A, Knaack M.
    Med Welt; 1973 Feb 23; 24(8):306-7. PubMed ID: 4688219
    [No Abstract] [Full Text] [Related]

  • 19. A long-term follow-up of fluphenazine enanthate treatment.
    Keskiner A.
    Curr Ther Res Clin Exp; 1973 Jun 23; 15(6):305-13. PubMed ID: 4197255
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of haloperidol in drug refractory patients.
    Ban TA, Lehmann HE.
    Int J Neuropsychiatry; 1967 Aug 23; 3():Suppl 1:78-86. PubMed ID: 4383142
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.